1. Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference
- Author
-
Sun Young Rha, Daniel G. Coit, Alfredo Berruti, Gian Luca Baiocchi, Masanori Terashima, Yasuhiro Kodera, Arnulf H. Hoelscher, Francesco Castelli, Stefan P. Mönig, Edwin P.M. Jansen, Natalie G. Coburn, Claudio Detogni, Cristoph Schuhmacher, Katia Ott, Takaki Yoshikawa, Servarayan Murugesan Chandramohan, Richard H. Hardwick, Paolo Morgagni, Christophe Mariette, Domenico D'Ugo, Daniele Marrelli, Mitsuru Sasako, Maurizio Memo, Sergio Pecorelli, Hans Joachim Meyer, Jimmy So Bok-yan, William H. Allum, Santiago González-Moreno, Cornelis Van der Velde, Atsushi Nashimoto, Giovanni de Manzoni, Michail Ter-Ovanesov, Shaun R. Preston, Hideaki Shimada, Vivian E. Strong, Paulo Kassab, Marcis Leja, Franco Roviello, and Takeshi Sano
- Subjects
Cancer Research ,medicine.medical_treatment ,Settore MED/18 - CHIRURGIA GENERALE ,Disease ,030230 surgery ,Endoscopy, Gastrointestinal ,Scientific evidence ,Upper gastrointestinal tract endoscopy ,0302 clinical medicine ,Surgical oncology ,Adjuvant ,ddc:617 ,Follow-up ,Gastroenterology ,Consensus conference ,General Medicine ,Plenary session ,Prognosis ,Local ,Oncology ,Chemotherapy, Adjuvant ,030220 oncology & carcinogenesis ,Tumor markers ,Practice Guidelines as Topic ,Neoplasm Recurrence, Local / diagnosis ,Gastrointestinal ,medicine.medical_specialty ,Consensus ,Stomach Neoplasms / drug therapy ,Article ,03 medical and health sciences ,Stomach Neoplasms ,Gastrectomy ,Physicians ,medicine ,Humans ,Chemotherapy ,Cross-sectional imaging ,Gastric cancer ,Surgery ,Follow-Up Studies ,Neoplasm Recurrence, Local ,business.industry ,General surgery ,Cancer ,Charter ,Endoscopy ,medicine.disease ,Neoplasm Recurrence ,business ,Stomach Neoplasms / surgery - Abstract
Presently, there is no scientific evidence supporting a definite role for follow-up after gastrectomy for cancer, and clinical practices are quite different around the globe. The aim of this consensus conference was to present an ideal prototype of follow-up after gastrectomy for cancer, based on shared experiences and taking into account the need to rationalize the diagnostic course without losing the possibility of detecting local recurrence at a potentially curable stage. On June 19–22, 2013 in Verona (Italy), during the 10th International Gastric Cancer Congress (IGCC) of the International Gastric Cancer Association, a consensus meeting was held, concluding a 6-month, Web-based, consensus conference entitled “Rationale of oncological follow-up after gastrectomy for cancer.” Forty-eight experts, with a geographical distribution reflecting different health cultures worldwide, participated in the consensus conference, and 39 attended the consensus meeting. Six statements were finally approved, displayed in a plenary session and signed by the vast majority of the 10th IGCC participants. These statements are attached as an annex to the Charter Scaligero on Gastric Cancer. After gastrectomy for cancer, oncological follow-up should be offered to patients; it should be tailored to the stage of the disease, mainly based on cross-sectional imaging, and should be discontinued after 5 years.
- Published
- 2016